UCB SA (UCB)

Basic

  • Market Cap

    €20.6B

  • EV

    €22.71B

  • Shares Out

    189.75M

  • Revenue

    €5,182M

  • Employees

    8,767

Margins

  • Gross

    67.06%

  • EBITDA

    24.49%

  • Operating

    11.15%

  • Pre-Tax

    8.51%

  • Net

    6.62%

  • FCF

    10.09%

Returns (5Yr Avg)

  • ROA

    4.5%

  • ROTA

    13.29%

  • ROE

    8.86%

  • ROCE

    9.06%

  • ROIC

    7.74%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    €105.22

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    €923M

  • Net Debt

    €2,115M

  • Debt/Equity

    0.34

  • EBIT/Interest

    4.01

Growth (CAGR)

  • Rev 3Yr

    -1.04%

  • Rev 5Yr

    2.27%

  • Rev 10Yr

    5.16%

  • Dil EPS 3Yr

    -22.42%

  • Dil EPS 5Yr

    -15.97%

  • Dil EPS 10Yr

    14.61%

  • Rev Fwd 2Yr

    0.64%

  • EBITDA Fwd 2Yr

    5.13%

  • EPS Fwd 2Yr

    -0.05%

  • EPS LT Growth Est

    7.5%

Dividends

  • Yield

  • Payout

    75.21%

  • DPS

    €1.36

  • DPS Growth 3Yr

    2.31%

  • DPS Growth 5Yr

    2.36%

  • DPS Growth 10Yr

    2.72%

  • DPS Growth Fwd 2Yr

    4.66%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

Revenues

4,758

5,148

5,550

5,225

4,944

Other Revenues, Total

155

199

227

222

238

Total Revenues

4,913

5,347

5,777

5,447

5,182

Total Revenues % Chg.

6.1%

8.8%

8%

-5.7%

-4.9%

Cost of Goods Sold, Total

1,268

1,363

1,438

1,674

1,707

Gross Profit

3,645

3,984

4,339

3,773

3,475

Selling General & Admin Expenses, Total

1,303

1,417

1,554

1,714

1,824

R&D Expenses

1,272

1,569

1,629

1,670

1,630

Other Operating Expenses

-41

-38

-158

-210

-557

Other Operating Expenses, Total

2,534

2,948

3,025

3,174

2,897

Operating Income

1,111

1,036

1,314

599

578

Interest Expense, Total

-60

-68

-45

-72

-144

Interest And Investment Income

17

14

9

12

30

Net Interest Expenses

-43

-54

-36

-60

-114

Income (Loss) On Equity Invest.

-1

2

Currency Exchange Gains (Loss)

-58

-38

-19

-7

-37

Other Non Operating Income (Expenses)

-5

-1

-4

-5

-12

EBT, Excl. Unusual Items

1,004

945

1,255

527

415

Restructuring Charges

-47

-20

-21

-42

-13

Merger & Related Restructuring Charges

-95

-41

Gain (Loss) On Sale Of Investments

Gain (Loss) On Sale Of Assets

48

50

-3

71

-26

Asset Writedown

-2

-6

-2

-5

Other Unusual Items

-42

-2

70

EBT, Incl. Unusual Items

961

880

1,225

511

441

Income Tax Expense

146

119

170

91

98

Earnings From Continuing Operations

815

761

1,055

420

343

Earnings Of Discontinued Operations

2

3

-2

Minority Interest

-25

-29

Net Income

792

732

1,058

418

343

Net Income to Common Incl Extra Items

792

732

1,058

418

343

Net Income to Common Excl. Extra Items

790

732

1,055

420

343

Total Shares Outstanding

188.6

189

189.2

189.6

189.8

Weighted Avg. Shares Outstanding

187.2

189

189

189.6

189.7

Weighted Avg. Shares Outstanding Dil

193

194.2

194.2

194.8

195.2

EPS

4.2

3.9

5.6

2.2

1.8

EPS Diluted

4.1

3.8

5.5

2.1

1.8

EBITDA

1,380

1,342

1,593

1,138

1,269